Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06155292 · ClinicalTrials.gov registry record · NA

Report Cards and Feedback for PCCE

A NA study of Primary Health Care and Behavioral Economics, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
330
Enrollment target
1
Study location

NCT06155292: Recruiting NA study of Primary Health Care and Behavioral Economics, sponsored by University of California, Los Angeles.

NCT06155292 is a NA study of Primary Health Care and Behavioral Economics that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 330 participants, below the 393-participant average among 8 other Primary Health Care trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06155292, a NA study of Primary Health Care and Behavioral Economics, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
330 participants
Enrollment target
1
Study location

Study Summary

As part of UCLA Health's commitment to developing an integrated health system built on a foundation of physician-led, team-based primary care, the Department of Medicine (DOM) implemented a performance-based incentive plan called the Primary Care Clinical Excellence (PCCE) Incentive Plan. The UCLA Health DOM Quality team is leading the implementation and evaluation of this incentive plan across the UCLA Health primary care network, with the primary goal to immediately produce improvements in the quality of primary care. In order to rigorously measure the most efficacious ways to frame and communicate information about the quality improvement (QI) program, the DOM Quality team has partnered with the UCLA Anderson School of Management. Understanding the factors that motivate physicians to deliver high quality primary care will provide pivotal insights into the successful implementation of performance based programs nationwide.

Primary Outcome

Whether physicians click through to access the "PCCE Resources and Improvement Strategies", for which a link is provided via quarterly report card emails. The time frame is one week after the first email was sent, as a binary indicator.

Interventions

  • BEHAVIORAL Standard Communication Email
  • BEHAVIORAL Personalized Report Card Email
  • BEHAVIORAL Bottom-Up Framing

Study Locations (1)

California

  • UCLA Health Department of Medicine, Quality Office - Los Angeles

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2023-10-03
Est. Completion 2025-10-31
Phase NA

What NCT06155292 shows while recruiting

NCT06155292 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 393-participant average among 8 other Primary Health Care trials with a reported enrollment target (16% lower).

The record links to 3 conditions, with Primary Health Care appearing as the primary indexed condition, and to 3 interventions - of which Standard Communication Email is the first listed.

NCT06155292 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06155292 about?

NCT06155292 is a clinical study titled "Report Cards and Feedback for PCCE". As part of UCLA Health's commitment to developing an integrated health system built on a foundation of physician-led, team-based primary care, the Department of Medicine (DOM) implemented a performance-based incentive plan called the Primary Care Clinical Excellence (PCCE) Incentive Plan. The UCLA ...

What is the current status of trial NCT06155292?

This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2023-10-03. Estimated completion is 2025-10-31.

What conditions does trial NCT06155292 study?

This clinical trial studies the following conditions: Primary Health Care, Behavioral Economics, Health Maintenance.

What interventions are being tested in trial NCT06155292?

The interventions under investigation include: Standard Communication Email (BEHAVIORAL), Personalized Report Card Email (BEHAVIORAL), Bottom-Up Framing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06155292?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06155292 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Health Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06155292's enrollment target sits among peer trials

330 6th of 8 higher than 3 of 8 other Primary Health Care trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Primary Health Care trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  • NCT03932773 · 330 participants · NA

    Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06155292, the US trial registry maintained by the National Library of Medicine. NCT06155292 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.